Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Net Income ContractionContracting
Percentile Rank18
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-155.20M
↓ 41% vs avg
Percentile
P18
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-110.41M
Historical baseline
PeriodValueYoY Change
TTM$-155.20M+25.4%
2024$-208.02M+38.6%
2023$-338.79M-304.2%
2022$-83.81M-27.4%
2021$-65.80M+18.7%
2020$-80.89M-3.4%
2019$-78.25M-76.5%
2018$-44.35M-62.8%
2017$-27.24M-25.5%
2016$-21.70M-